Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News Sulfonamides: Origins, mechanisms, and clinical relevance Sulfonamides, a landmark discovery in antimicrobial therapy, revolutionized the treatment of bacterial infections. These compounds, characterized by their… bypharmanewsdailyJanuary 5, 2025